In April 2015, an FDA panel said that Onglyza should label a warning about the increased risk of heart failure. Further data from the SAVOR study involving 16,000 patients found that people who took Onglyza…

Lawyers across America are investigating Risperdal lawsuits on the authority of young boys who have ostensibly developed male breast tissues due to the consumption of the antipsychotic drug Risperdal.

In May 2016 Ethicon Inc., a Johnson & Johnson subsidiary, announced a voluntary withdrawal of its Physiomesh Composite Mesh. The withdrawal was issued after the Physiomesh patch was found to have higher than average revision…